ALPS Medical Breakthroughs ETF (SBIO) targets late-stage clinical biotech firms poised for FDA approval or acquisition, offering high-risk, high-reward exposure. SBIO surged 91% over the past year, ...

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the ALPS Medical Breakthroughs ETF (SBIO), a passively managed exchange traded fund ...

Medical bioengineering is reshaping modern healthcare by merging biology, engineering, and advanced computational systems to create precise and personalized treatments. Through innovations like CRISPR ...

Former official David Mansdoerfer argues that bureaucratic delays at the FDA threaten American leadership in the growing regenerative medicine sector and give international competitors like China ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Top academic and healthcare institutions partner to build $500 million non-profit venture to turn promising biotech research ...

AI-driven innovation is rapidly reshaping the scientific ecosystem and redefining long-term value creation across healthcare, biotech, and life sciences. This session will explore the key forces ...

DUBLIN and WILSONVILLE, Ore., July 22, 2026 (GLOBE NEWSWIRE)-- Trinity Biotech plc (NASDAQ: TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of ...

December 2025 marked an exceptionally active period for life sciences regulation in the European Union (EU). Within the space of a few days, EU institutions have reached political agreement on the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...